Evaxion Biotech AS is a biotechnology business based in the US. Evaxion Biotech AS shares (EVAX) are listed on the NASDAQ and all prices are listed in US Dollars. Evaxion Biotech AS employs 61 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Evaxion Biotech AS
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – EVAX – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Evaxion Biotech AS stock price (NASDAQ: EVAX)Use our graph to track the performance of EVAX stocks over time.
Evaxion Biotech AS shares at a glance
|Latest market close||$2.98|
|52-week range||$1.51 - $12.68|
|50-day moving average||$2.57|
|200-day moving average||$2.79|
|Wall St. target price||$15.50|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-1.26|
Buy Evaxion Biotech AS shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Evaxion Biotech AS stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Evaxion Biotech AS price performance over time
|1 week (2022-09-28)||7.58%|
|1 month (2022-09-06)||40.57%|
|3 months (2022-07-06)||37.96%|
|6 months (2022-04-06)||-0.33%|
|1 year (2021-10-06)||-65.75%|
|2 years (2020-10-02)||N/A|
|3 years (2019-10-02)||N/A|
|5 years (2017-10-02)||N/A|
Evaxion Biotech AS financials
|Gross profit TTM||$0|
|Return on assets TTM||-53.3%|
|Return on equity TTM||-115.2%|
|Market capitalisation||$63.1 million|
TTM: trailing 12 months
Evaxion Biotech AS share dividends
We're not expecting Evaxion Biotech AS to pay a dividend over the next 12 months.
Evaxion Biotech AS overview
Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies for cancers, bacterial diseases, and viral infections. The company develops EVX-01, a cancer immunotherapy that is in clinical Phase IIb trial for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy that is in Phase IIa trial for adjuvant melanoma; and EVX-03, a DNA-based immunotherapy for the treatment of various cancers. Its programs also include EVX-B1, EVX-B2, and EVX-V1, which are vaccines that are in pre-clinical stage for the treatment of bacterial and viral diseases. The company was incorporated in 2008 and is headquartered in Hørsholm, Denmark. .
Evaxion Biotech AS in the news
Evaxion welcomes Per Norlén as new CEO.
Evaxion welcomes Per Norlén as new CEO.
Evaxion (EVAX) Enrolls First Patient in Phase IIb Melanoma Study
Frequently asked questionsWhat percentage of Evaxion Biotech AS is owned by insiders or institutions?
Currently 42.473% of Evaxion Biotech AS shares are held by insiders and 1.951% by institutions. How many people work for Evaxion Biotech AS?
Latest data suggests 61 work at Evaxion Biotech AS. When does the fiscal year end for Evaxion Biotech AS?
Evaxion Biotech AS's fiscal year ends in December. Where is Evaxion Biotech AS based?
Evaxion Biotech AS's address is: Dr. Neergaards Vej, Horsholm, Denmark, 2970 What is Evaxion Biotech AS's ISIN number?
Evaxion Biotech AS's international securities identification number is: US29970R1059
More guides on Finder
Alternatives to Webull
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
Best renewable energy stocks for 2022
Here are the best renewable energy stocks that should be on your radar to help you grow your green portfolio
Here are 6 manganese stocks that should be on your radar as EV batteries create new demand.
The best dividend stocks for 2022
Our list of 10 dividend stocks to watch in 2022.
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
Invest in FAANG stocks
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
Ask an Expert